93 related articles for article (PubMed ID: 26232556)
1. Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells.
Vazquez-Mellado MJ; Aguilar C; Rocha-Zavaleta L
Life Sci; 2015 Sep; 137():142-9. PubMed ID: 26232556
[TBL] [Abstract][Full Text] [Related]
2. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Liu SQ; Yu JP; Yu HG; Lv P; Chen HL
Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552
[TBL] [Abstract][Full Text] [Related]
3. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
4. Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity.
Pallet N; Bouvier N; Legendre C; Beaune P; Thervet E; Choukroun G; Martinez F
Pharmacol Res; 2010 Jan; 61(1):71-5. PubMed ID: 19766721
[TBL] [Abstract][Full Text] [Related]
5. Perampanel Inhibits Neuroblastoma Cell Proliferation Through Down-regulation of AKT and ERK Pathways.
Nozawa A; Ozeki M; Matsuoka M; Nakama M; Yasue S; Endo S; Kawamoto N; Ohnishi H; Fukao T
Anticancer Res; 2019 Jul; 39(7):3595-3599. PubMed ID: 31262884
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin.
Andreucci M; Fuiano G; Presta P; Lucisano G; Leone F; Fuiano L; Bisesti V; Esposito P; Russo D; Memoli B; Faga T; Michael A
Cell Prolif; 2009 Aug; 42(4):554-61. PubMed ID: 19508320
[TBL] [Abstract][Full Text] [Related]
8. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
10. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of nemorosone in neuroblastoma cells.
Díaz-Carballo D; Malak S; Bardenheuer W; Freistuehler M; Reusch HP
J Cell Mol Med; 2008 Dec; 12(6B):2598-608. PubMed ID: 18194446
[TBL] [Abstract][Full Text] [Related]
12. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death.
Signore AP; Weng Z; Hastings T; Van Laar AD; Liang Q; Lee YJ; Chen J
J Neurochem; 2006 Jan; 96(2):428-43. PubMed ID: 16336625
[TBL] [Abstract][Full Text] [Related]
14. Erratum to "Erythropoietin protects neuroblastoma cells against etoposide and vincristine by activating ERK and AKT pathways but has no effect in kidney cells" [Life Sci. 137(2015) 142-149].
Vazquez-Mellado MJ; Aguilar C; Rocha-Zavaleta L
Life Sci; 2017 Mar; 172():1. PubMed ID: 28259205
[No Abstract] [Full Text] [Related]
15. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling.
Zhang J; Zou YR; Zhong X; Deng HD; Pu L; Peng K; Wang L
Nephrology (Carlton); 2015 Apr; 20(4):266-72. PubMed ID: 25581532
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia promotes etoposide (VP-16) resistance in neuroblastoma CHP126 cells.
Wang D; Zhu Q; Zhang X; Zhang L; He Q; Yang B
Pharmazie; 2010 Jan; 65(1):51-6. PubMed ID: 20187579
[TBL] [Abstract][Full Text] [Related]
18. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation.
de Miranda Ramos V; Zanotto-Filho A; de Bittencourt Pasquali MA; Klafke K; Gasparotto J; Dunkley P; Gelain DP; Moreira JCF
Mol Neurobiol; 2016 Nov; 53(9):6124-6135. PubMed ID: 26541884
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
20. Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells.
Pregi N; Vittori D; Pérez G; Leirós CP; Nesse A
Biochim Biophys Acta; 2006 Feb; 1763(2):238-46. PubMed ID: 16500719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
